Retour
59
Fourchette du Jour
70,25 €
73,28 €
Fourchette 52 Semaines
58,35 €
85,15 €
Volume
6 617 443
Moyenne 50J / 200J
77,57 €
/
74,12 €
Clôture Précédente
71,29 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 52,4 | 0,4 |
| P/B | 1,2 | 2,9 |
| ROE % | 2,4 | 3,9 |
| Net Margin % | 0,4 | 3,8 |
| Rev Growth 5Y % | 8,3 | 10,0 |
| D/E | 1,2 | 0,2 |
Objectif de Cours des Analystes
Hold
95,15 €
+30.7%
Low: 90,00 €
High: 103,00 €
P/E Prévisionnel
10,0
BPA Prévisionnel
7,17 €
Croissance BPA (est.)
+0,0%
CA Est.
410 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
11,47 €
10,95 € – 12,14 €
|
500 B | 4 |
| FY2029 |
10,47 €
10,00 € – 11,08 €
|
480 B | 4 |
| FY2028 |
9,41 €
8,57 € – 11,16 €
|
450 B | 10 |
Points Clés
Revenue grew 8,31% annually over 5 years — modest growth
Earnings declined -61,68% over the past year
ROE of 2,35% is below average
Generating 7,81B in free cash flow
P/E of 52,39 — premium valuation
Cash machine — converts 441,57% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
8,31%
Revenue (1Y)7,85%
Earnings (1Y)-61,68%
FCF Growth (3Y)-13,34%
Qualité
Return on Equity
2,35%
ROIC4,61%
Net Margin0,44%
Op. Margin2,58%
Sécurité
Debt / Equity
1,24
Current Ratio0,84
Interest Coverage3,33
Valorisation
P/E Ratio
52,39
P/B Ratio1,23
EV/EBITDA17,11
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,85% | Revenue Growth (3Y) | 6,01% |
| Earnings Growth (1Y) | -61,68% | Earnings Growth (3Y) | -53,97% |
| Revenue Growth (5Y) | 8,31% | Earnings Growth (5Y) | -31,44% |
| Profitability | |||
| Revenue (TTM) | 402,07B | Net Income (TTM) | 1,77B |
| ROE | 2,35% | ROA | 0,68% |
| Gross Margin | 13,77% | Operating Margin | 2,58% |
| Net Margin | 0,44% | Free Cash Flow (TTM) | 7,81B |
| ROIC | 4,61% | FCF Growth (3Y) | -13,34% |
| Safety | |||
| Debt / Equity | 1,24 | Current Ratio | 0,84 |
| Interest Coverage | 3,33 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 52,39 | P/B Ratio | 1,23 |
| P/S Ratio | 0,23 | PEG Ratio | -0,92 |
| EV/EBITDA | 17,11 | Dividend Yield | 0,03% |
| Market Cap | 92,62B | Enterprise Value | 177,70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 402,07B | 372,81B | 357,78B | 322,47B | 292,11B |
| Net Income | 1,77B | 4,61B | 8,34B | 4,31B | 8,00B |
| EPS (Diluted) | 1,39 | 3,66 | 6,47 | 3,26 | 5,95 |
| Gross Profit | 55,36B | 51,40B | 54,43B | 54,50B | 52,12B |
| Operating Income | 10,39B | 8,52B | 13,74B | 7,95B | 13,31B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 261,06B | 253,22B | 249,73B | 228,28B | 233,00B |
| Total Liabilities | 185,68B | 177,49B | 173,09B | 156,51B | 157,62B |
| Shareholders' Equity | 75,21B | 75,56B | 76,46B | 71,47B | 75,08B |
| Total Debt | 93,59B | 82,92B | 79,39B | 70,73B | 76,00B |
| Cash & Equivalents | 8,51B | 8,59B | 8,20B | 12,95B | 9,41B |
| Current Assets | 74,71B | 68,65B | 67,86B | 65,63B | 60,01B |
| Current Liabilities | 88,69B | 84,61B | 79,19B | 69,42B | 67,81B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#241 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026